711 related articles for article (PubMed ID: 22981278)
1. MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis.
Lu F; Zhao X; Wu J; Cui Y; Mao Y; Chen K; Yuan Y; Gong D; Xu Z; Huang S
Int J Cardiol; 2013 Sep; 167(6):2524-32. PubMed ID: 22981278
[TBL] [Abstract][Full Text] [Related]
2. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.
Yang ZJ; Ma DC; Wang W; Xu SL; Zhang YQ; Chen B; Zhou F; Zhu TB; Wang LS; Xu ZQ; Zhang FM; Cao KJ; Ma WZ
Gene Ther; 2006 Nov; 13(22):1564-8. PubMed ID: 16810195
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.
Deuse T; Peter C; Fedak PW; Doyle T; Reichenspurner H; Zimmermann WH; Eschenhagen T; Stein W; Wu JC; Robbins RC; Schrepfer S
Circulation; 2009 Sep; 120(11 Suppl):S247-54. PubMed ID: 19752375
[TBL] [Abstract][Full Text] [Related]
4. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction.
Yang J; Zhou W; Zheng W; Ma Y; Lin L; Tang T; Liu J; Yu J; Zhou X; Hu J
Cardiology; 2007; 107(1):17-29. PubMed ID: 16741354
[TBL] [Abstract][Full Text] [Related]
5. Effects of hepatocyte growth factor overexpressed bone marrow-derived mesenchymal stem cells on prevention from left ventricular remodelling and functional improvement in infarcted rat hearts.
Wang S; Qin X; Sun D; Wang Y; Xie X; Fan W; Wang Y; Liang D; Pei X; Cao F
Cell Biochem Funct; 2012 Oct; 30(7):574-81. PubMed ID: 22592978
[TBL] [Abstract][Full Text] [Related]
6. [Effect of combined therapy of granulocyte colony stimulating factor and bone marrow mesenchymal stem cells carrying hepatocyte growth factor gene on angiogenesis of myocardial infarction in rats].
Guo Y; Liu C; He J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Jun; 25(6):736-40. PubMed ID: 21735790
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
Tang J; Xie Q; Pan G; Wang J; Wang M
Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.
Tang J; Wang J; Yang J; Kong X; Zheng F; Guo L; Zhang L; Huang Y
Eur J Cardiothorac Surg; 2009 Oct; 36(4):644-50. PubMed ID: 19524448
[TBL] [Abstract][Full Text] [Related]
9. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
[TBL] [Abstract][Full Text] [Related]
10. [Effects of myocardial transplantation of mesenchymal stem cells transfected with vascular endothelial factor gene on improvement of heart function and angiogenesis after myocardial infarction: experiment with rats].
Yang JF; Zhou WW; Tang T; Yu JF; Zhou XM; Hu JG
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(15):1027-34. PubMed ID: 16784704
[TBL] [Abstract][Full Text] [Related]
11. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
[TBL] [Abstract][Full Text] [Related]
12. Outcome improvement of cellular cardiomyoplasty using triple therapy: mesenchymal stem cell+erythropoietin+vascular endothelial growth factor.
Tavakoli F; Ostad SN; Khori V; Alizadeh AM; Sadeghpour A; Darbandi Azar A; Haghjoo M; Zare A; Nayebpour M
Eur J Pharmacol; 2013 Aug; 714(1-3):456-63. PubMed ID: 23850947
[TBL] [Abstract][Full Text] [Related]
13. [Hepatocyte growth factor did not enhance the effects of bone marrow-derived mesenchymal stem cells transplantation on cardiac repair in a porcine acute myocardial infarction model].
Ma DC; Yang ZJ; Wang W; Xu SL; Zhang YQ; Zhou F; Chen B; Xu ZQ; Cao KJ; Ma WZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Feb; 34(2):119-22. PubMed ID: 16626576
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor modification enhances the anti-arrhythmic properties of human bone marrow-derived mesenchymal stem cells.
Zhang J; Wang LL; Du W; Yu YC; Ju WZ; Man YL; Li XR; Chen Y; Wang ZD; Gu WJ; Zhang FX; Wang H; Wu CT; Cao KJ
PLoS One; 2014; 9(10):e111246. PubMed ID: 25360679
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction.
Liu C; Fan Y; Zhou L; Zhu HY; Song YC; Hu L; Wang Y; Li QP
Int J Cardiol; 2015 Jun; 188():22-32. PubMed ID: 25880576
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
Guo YH; He JG; Wu JL; Yang L; Zhang DS; Tan XY; Qi RD
Cytotherapy; 2008; 10(8):857-67. PubMed ID: 18956268
[TBL] [Abstract][Full Text] [Related]
17. Wharton's jelly-derived mesenchymal stem cells promote myocardial regeneration and cardiac repair after miniswine acute myocardial infarction.
Zhang W; Liu XC; Yang L; Zhu DL; Zhang YD; Chen Y; Zhang HY
Coron Artery Dis; 2013 Nov; 24(7):549-58. PubMed ID: 23892469
[TBL] [Abstract][Full Text] [Related]
18. Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction.
Halkos ME; Zhao ZQ; Kerendi F; Wang NP; Jiang R; Schmarkey LS; Martin BJ; Quyyumi AA; Few WL; Kin H; Guyton RA; Vinten-Johansen J
Basic Res Cardiol; 2008 Nov; 103(6):525-36. PubMed ID: 18704259
[TBL] [Abstract][Full Text] [Related]
19. Transplantation of mesenchymal stem cells carrying the human receptor activity-modifying protein 1 gene improves cardiac function and inhibits neointimal proliferation in the carotid angioplasty and myocardial infarction rabbit model.
Shi B; Long X; Zhao R; Liu Z; Wang D; Xu G
Exp Biol Med (Maywood); 2014 Mar; 239(3):356-65. PubMed ID: 24477823
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
